首页> 外文期刊>Archiv der Pharmazie >Synthesis and antimicrobial activity of (2-(2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino) thiazol-4-yl)acetic acid ethyl esters.
【24h】

Synthesis and antimicrobial activity of (2-(2-(N, N-disubstituted thiocarbamoyl-sulfanyl)-acylamino) thiazol-4-yl)acetic acid ethyl esters.

机译:(2-(2-(N,N-二取代硫代氨基甲酰基-硫烷基)-酰基氨基)噻唑-4-基)乙酸乙酯的合成及抗菌活性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

[2-[2-(N, N-Disubstituted thiocarbamoyl-sulfanyl)acylamino ]thiazol-4-yl]acetic acid ethyl esters (3a-x) were synthesized by the reaction of potassium salts of N, N-disubstituted dithiocarbamoic acids with [2-(2-chloroalkanoyl)amino-thiazol-4-yl]acetic acid ethyl esters. The structures of the synthesized compounds were confirmed by elemental analyses, UV, IR, (1)H-NMR, and EI mass spectral data. The antimicrobial activities of all the compounds were investigated by microbroth dilution technique using Mueller-Hinton broth and Mueller-Hinton agar. In this study, Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228, Escherichia coli ATCC 8739, Klebsiella pneumoniae ATCC 4352, Pseudomonas aeruginosa AT CC 1539, Salmonella typhi, Shigella flexneri, Proteus mirabilis ATCC 14153 and Candida albicans ATCC10231 were used as test microorganisms. Among the tested compounds 3a, d, e, f, h, k, w activity against S. epidermidis ATCC 12228 (MIC: 156 mg/L, 78 mg/L, 62.5 mg/L, 78 mg/L, 62.5 mg/L, 312 mg/L, 250 mg/L, respectively), compound 3d had some activity against S. aureus ATCC 6538 (MIC: 156 mg/L) and C. albicans ATCC 10231(MIC: 156 mg/L). Compounds 3l, 3x also evaluated for antituberculosis activity against Mycobacterium tuberculosis H37Rv using the BACTEC 460 radiometric system and BACTEC 12B medium. The preliminary results indicated that all of the tested compounds were inactive against the test organism.
机译:通过使N,N-二取代的二硫代氨基甲酸酯酸的钾盐与[N-N-N-N-二取代的硫代氨基甲酰基-硫烷基] [乙酰基氨基]噻唑-4-基]乙酸乙酯(3a-x)合成[2-(2-氯链烷酰基)氨基-噻唑-4-基]乙酸乙酯。通过元素分析,UV,IR,(1)H-NMR和EI质谱数据确认了合成化合物的结构。通过使用Mueller-Hinton肉汤和Mueller-Hinton琼脂的微肉汤稀释技术研究了所有化合物的抗菌活性。在这项研究中,分别使用了金黄色葡萄球菌ATCC 14153和金黄色葡萄球菌ATCC 14153,分别使用了金黄色葡萄球菌ATCC 6538,表皮葡萄球菌ATCC 12228,大肠杆菌ATCC 8739,肺炎克雷伯菌ATCC 4352,铜绿假单胞菌AT CC 1539,伤寒沙门氏菌,志贺氏志贺氏菌,102埃斯氏菌ATCC 14153。在测试的化合物3a,d,e,f,h,k,w中具有对抗表皮葡萄球菌ATCC 12228的活性(MIC:156 mg / L,78 mg / L,62.5 mg / L,78 mg / L,62.5 mg /分别为L,312 mg / L,250 mg / L),化合物3d对金黄色葡萄球菌ATCC 6538(MIC:156 mg / L)和白色念珠菌ATCC 10231(MIC:156 mg / L)具有一定的活性。化合物3l,3x还使用BACTEC 460放射系统和BACTEC 12B培养基评估了针对结核分枝杆菌H37Rv的抗结核活性。初步结果表明,所有被测化合物对被测生物均无活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号